YG
Yadehalli Gundurao Ramya
About Yadehalli Gundurao Ramya
Data last updated:
Yadehalli Gundurao Ramya is a Director at Avance Clinical India Private Limited (since 2023). The company operates in Healthcare. Avance Clinical India Private Limited reported revenue of ₹9.35 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Avance Clinical India Private Limited U73100KA2022FTC167429 | Director | 22 Sep 2023 | 2022 | ₹9.35 Cr (FY 2025) | Active |
Board colleagues of Yadehalli Gundurao Ramya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gregory Charles Vella | 09776284 | Avance Clinical India Private Limited | Director |
| Mark Landon Harvill | 11219851 | Avance Clinical India Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Yadehalli Gundurao Ramya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yadehalli Gundurao Ramya
Yadehalli Gundurao Ramya currently holds 1 directorship: Avance Clinical India Private Limited (Director, since 22 Sep 2023, revenue ₹9.35 Cr (FY 2025)).
Yadehalli Gundurao Ramya was first appointed on 22 Sep 2023 as Director at Avance Clinical India Private Limited.
The current boards of Yadehalli Gundurao Ramya's companies include Gregory Charles Vella (Avance Clinical India Private Limited), Mark Landon Harvill (Avance Clinical India Private Limited).